List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 231 studies with search of: Lopinavir/ Ritonavir OR Kaletra[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Lopinavir/Ritonavir (Kaletra)PK
Conditions: HIV/AIDS Treatment;   HIV Infections
Intervention: Drug: lopinavir/ritonavir (Kaletra®) tablets
2 Enrolling by invitation Comparison of Liquid Kaletra and Low Dose Kaletra Tablets
Condition: HIV Infections
Intervention: Drug: Low dose Kaletra tablets
3 Completed Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)
Condition: HIV Infections
Interventions: Drug: Kaletra (lopinavir/ritonavir);   Drug: buprenorphine;   Other: Clinical evaluations/Blood draws
4 Completed Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients
Condition: HIV Infection
Interventions: Drug: Tenofovir DF;   Drug: lopinavir/ritonavir with 2 Nucleoside RTIs
5 Terminated Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV co-Infected Subjects vs Baseline Liver Biopsy Metavir Score
Condition: HIV Infection
Intervention: Drug: Lopinavir/Ritonavir
6 Terminated Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients
Conditions: HIV Infections;   Kaletra
Interventions: Drug: lopinavir/ritonavir;   Drug: lopinavir /ritonavir
7 Recruiting Lopinavir Capsules to Kaletra or Invirase Tablets
Condition: HIV Infections
Interventions: Drug: Saquinavir (Invirase®);   Drug: Lopinavir/ritonavir (Kaletra®)
8 Recruiting Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-Partum Phase. ANRS 135 Primeva
Condition: HIV Infections
Interventions: Drug: Kaletra (lopinavir/ritonavir);   Drug: Kaletra (lopinavir/ritonavir) + Combivir (zidovudine/lamivudine)
9 Completed Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients
Condition: HIV Infection
Interventions: Drug: lopinavir/ritonavir;   Drug: lamivudine/zidovudine
10 Completed Metabolic Effects of Switching Kaletra to Boosted Reyataz
Condition: HIV Infections
Interventions: Drug: atazanavir/ritonavir;   Drug: lopinavir/ritonavir
11 Recruiting Kaletra Monotherapy in HIV/HCV Co-Infected Subjects
Condition: HIV Infections
Intervention: Drug: Kaletra Tablets
12 Recruiting Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients
Condition: HIV Infections
Intervention: Drug: Kaletra
13 Completed A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects
Condition: HIV Infections
Interventions: Drug: Kaletra® (lopinavir/ritonavir);   Drug: Combivir® (lamivudine, zidovudine);   Drug: Sustiva® (efavirenz)
14 Recruiting Kaletra-isentress Treatment Evaluation
Condition: HIV Infections
Interventions: Drug: Kaletra + Isentress;   Drug: Standard HAART Regimen
15 Recruiting Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: AZT+3TC+ABV (Trizivir);   Drug: Switching to LPV/r monotherapy (Kaletra)
16 Recruiting Kaletra Sex/Gender Pharmacokinetics (PK) Study: A Switch From Twice Daily to Once Daily Lopinavir/Ritonavir
Condition: HIV Infections
Intervention: Drug: Kaletra
17 Recruiting Kaletra and Viread in Antiretroviral Naïve Patients
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir and tenofovir
18 Terminated GW873140 In Combination With Kaletra In HIV Infected Subjects
Condition: HIV Infection
Interventions: Drug: GW873140;   Drug: Kaletra (lopinavir/ritonavir)
19 Completed ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial
Condition: HIV-1
Interventions: Drug: Truvada (emtricitabine 200 mg/tenofovir DF 300 mg) and Kaletra (lopinavir 200 mg/ritonavir;   Drug: Kivexa (abacavir (as sulfate) 600 mg/lamivudine and Kaletra (lopinavir 200 mg/ritonavir
20 Completed
Has Results 		Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects
Condition: Human Immunodeficiency Virus Infections
Intervention: Drug: lopinavir/ritonavir (LPV/r) (tablet or capsule) with nucleoside reverse transcriptase inhibitors (NRTIs)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services